Characterization of the human papillomavirus 16 E8 promoter

Journal of Virology

Volumn 89, Issue 14, 2015, Pages 7304-7313

  Straub, Elke ^a   Fertey, Jasmin ^a   Dreer, Marcel ^a   Iftner, Thomas ^a   Stubenrauch, Frank ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN E1; PROTEIN E2; PROTEIN E8; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA;

ARTICLE; CONTROLLED STUDY; ENHANCER REGION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; KERATINOCYTE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; VIRUS GENOME; VIRUS REPLICATION; CELL CULTURE; GENE DELETION; GENETICS; NUCLEOTIDE SEQUENCE; POINT MUTATION; TRANSCRIPTION INITIATION; VIROLOGY;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS - 16; HUMAN PAPILLOMAVIRUS TYPE 16; PAPILLOMAVIRIDAE;

CELLS, CULTURED; DNA MUTATIONAL ANALYSIS; HUMAN PAPILLOMAVIRUS 16; HUMANS; KERATINOCYTES; POINT MUTATION; PROMOTER REGIONS, GENETIC; SEQUENCE DELETION; TRANSCRIPTIONAL ACTIVATION;

EID: 84931028760     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00616-15     Document Type: Article

References (42)

1. Cogliano V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F. 2005. Carcinogenicity of human papillomaviruses. Lancet Oncol 6:204. http://dx.doi.org/10.1016/S1470-2045(05)70086-3.
2. Parkin DM, Bray F. 2006. Chapter 2: the burden of HPV-related cancers. Vaccine 24(Suppl 3):S3/11-25. http://dx.doi.org/10.1016/j.vaccine.2005.01.101.
3. Schiffman M, Clifford G, Buonaguro FM. 2009. Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline. Infect Agents Cancer 4:8. http://dx.doi.org/10.1186/1750-9378-4-8.
4. zur Hausen H. 2002. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2:342-350. http://dx.doi.org/10.1038/nrc798.
5. Stubenrauch F, Laimins LA. 1999. Human papillomavirus life cycle: active and latent phases. Semin Cancer Biol 9:379-386. http://dx.doi.org/10.1006/scbi.1999.0141.
6. Stenlund A. 2003. Initiation of DNA replication: lessons from viral initiator proteins. Nat Rev Mol Cell Biol 4:777-785. http://dx.doi.org/10.1038/nrm1226.
7. Fertey J, Hurst J, Straub E, Schenker A, Iftner T, Stubenrauch F. 2011. Growth inhibition of HeLa cells is a conserved feature of high-risk human papillomavirus E8^E2C proteins and can also be achieved by an artificial repressor protein. J Virol 85:2918-2926. http://dx.doi.org/10.1128/JVI.01647-10.
8. Kurg R, Uusen P, Vosa L, Ustav M. 2010. Human papillomavirus E2 protein with single activation domain initiates HPV18 genome replication, but is not sufficient for long-term maintenance of virus genome. Virology 408:159-166. http://dx.doi.org/10.1016/j.virol.2010.09.010.
9. Lace MJ, Anson JR, Thomas GS, Turek LP, Haugen TH. 2008. The E8-E2 gene product of human papillomavirus type 16 represses early transcription and replication but is dispensable for viral plasmid persistence in keratinocytes. J Virol 82:10841-10853. http://dx.doi.org/10.1128/JVI.01481-08.
10. Stubenrauch F, Hummel M, Iftner T, Laimins LA. 2000. The E8^E2C protein, a negative regulator of viral transcription and replication, is required for extrachromosomal maintenance of human papillomavirus type 31 in keratinocytes. J Virol 74:1178-1186. http://dx.doi.org/10.1128/JVI.74.3.1178-1186.2000.
11. Straub E, Dreer M, Fertey J, Iftner T, Stubenrauch F. 2014. The viral E8^E2C repressor limits productive replication of human papillomavirus 16. J Virol 88:937-947. http://dx.doi.org/10.1128/JVI.02296-13.
12. Stubenrauch F, Zobel T, Iftner T. 2001. The E8 domain confers a novel long-distance transcriptional repression activity on the E8^E2C protein of high-risk human papillomavirus type 31. J Virol 75:4139-4149. http://dx.doi.org/10.1128/JVI.75.9.4139-4149.2001.
13. Toots M, Mannik A, Kivi G, Ustav M, Jr, Ustav E, Ustav M. 2014. The transcription map of human papillomavirus type 18 during genome replication in U2OS cells. PLoS One 9:e116151. http://dx.doi.org/10.1371/journal.pone.0116151.
14. Zobel T, Iftner T, Stubenrauch F. 2003. The papillomavirus E8-E2C protein represses DNA replication from extrachromosomal origins. Mol Cell Biol 23:8352-8362. http://dx.doi.org/10.1128/MCB.23.22.8352-8362.2003.
15. Ammermann I, Bruckner M, Matthes F, Iftner T, Stubenrauch F. 2008. Inhibition of transcription and DNA replication by the papillomavirus E8-E2C protein is mediated by interaction with corepressor molecules. J Virol 82:5127-5136. http://dx.doi.org/10.1128/JVI.02647-07.
16. Powell ML, Smith JA, Sowa ME, Harper JW, Iftner T, Stubenrauch F, Howley PM. 2010. NCoR1 mediates papillomavirus E8;E2C transcriptional repression. J Virol 84:4451-4460. http://dx.doi.org/10.1128/JVI.02390-09.
17. Grassmann K, Rapp B, Maschek H, Petry KU, Iftner T. 1996. Identification of a differentiation-inducible promoter in the E7 open reading frame of human papillomavirus type 16 (HPV-16) in raft cultures of a new cell line containing high copy numbers of episomal HPV-16 DNA. J Virol 70:2339-2349.
18. Hummel M, Hudson JB, Laimins LA. 1992. Differentiation-induced and constitutive transcription of human papillomavirus type 31b in cell lines containing viral episomes. J Virol 66:6070-6080.
19. Wang X, Meyers C, Wang HK, Chow LT, Zheng ZM. 2011. Construction of a full transcription map of human papillomavirus type 18 during productive viral infection. J Virol 85:8080-8092. http://dx.doi.org/10.1128/JVI.00670-11.
20. Alloul N, Sherman L. 1999. The E2 protein of human papillomavirus type 16 is translated from a variety of differentially spliced polycistronic mRNAs. J Gen Virol 80(Part 1):29-37.
21. Remm M, Remm A, Ustav M. 1999. Human papillomavirus type 18 E1 protein is translated from polycistronic mRNA by a discontinuous scanning mechanism. J Virol 73:3062-3070.
22. Tan TM, Gloss B, Bernard HU, Ting RC. 1994. Mechanism of translation of the bicistronic mRNA encoding human papillomavirus type 16 E6-E7 genes. J Gen Virol 75(Part 10):2663-2670. http://dx.doi.org/10.1099/0022-1317-75-10-2663.
23. Milligan SG, Veerapraditsin T, Ahamet B, Mole S, Graham SV. 2007. Analysis of novel human papillomavirus type 16 late mRNAs in differentiated W12 cervical epithelial cells. Virology 360:172-181. http://dx.doi.org/10.1016/j.virol.2006.10.012.
24. Chen J, Xue Y, Poidinger M, Lim T, Chew SH, Pang CL, Abastado JP, Thierry F. 2014. Mapping of HPV transcripts in four human cervical lesions using RNAseq suggests quantitative rearrangements during carcinogenic progression. Virology 462-463:14-24. http://dx.doi.org/10.1016/j.virol.2014.05.026.
25. Purdie KJ, Sexton CJ, Proby CM, Glover MT, Williams AT, Stables JN, Leigh IM. 1993. Malignant transformation of cutaneous lesions in renal allograft patients: a role for human papillomavirus. Cancer Res 53:5328-5333.
26. Soeda E, Ferran MC, Baker CC, McBride AA. 2006. Repression of HPV16 early region transcription by the E2 protein. Virology 351:29-41. http://dx.doi.org/10.1016/j.virol.2006.03.016.
27. Untergasser A, Nijveen H, Rao X, Bisseling T, Geurts R, Leunissen JA. 2007. Primer3Plus, an enhanced web interface to Primer3. Nucleic Acids Res 35:W71-W74. http://dx.doi.org/10.1093/nar/gkm306.
28. Bodily JM, Hennigan C, Wrobel GA, Rodriguez CM. 2013. Regulation of the human papillomavirus type 16 late promoter by E7 and the cell cycle. Virology 443:11-19. http://dx.doi.org/10.1016/j.virol.2013.04.033.
29. Kukimoto I, Kanda T. 2001. Displacement of YY1 by differentiationspecific transcription factor hSkn-1a activates the P(670) promoter of human papillomavirus type 16. J Virol 75:9302-9311. http://dx.doi.org/10.1128/JVI.75.19.9302-9311.2001.
30. Bodily JM, Meyers C. 2005. Genetic analysis of the human papillomavirus type 31 differentiation-dependent late promoter. J Virol 79:3309-3321. http://dx.doi.org/10.1128/JVI.79.6.3309-3321.2005.
31. McBride AA. 2013. The papillomavirus E2 proteins. Virology 445:57-79. http://dx.doi.org/10.1016/j.virol.2013.06.006.
32. McBride AA, Jang MK. 2013. Current understanding of the role of the Brd4 protein in the papillomavirus lifecycle. Viruses 5:1374-1394. http://dx.doi.org/10.3390/v5061374.
33. McPhillips MG, Oliveira JG, Spindler JE, Mitra R, McBride AA. 2006. Brd4 is required for e2-mediated transcriptional activation but not genome partitioning of all papillomaviruses. J Virol 80:9530-9543. http://dx.doi.org/10.1128/JVI.01105-06.
34. Sakai H, Yasugi T, Benson JD, Dowhanick JJ, Howley PM. 1996. Targeted mutagenesis of the human papillomavirus type 16 E2 transactivation domain reveals separable transcriptional activation and DNA replication functions. J Virol 70:1602-1611.
35. Schweiger MR, You J, Howley PM. 2006. Bromodomain protein 4 mediates the papillomavirus E2 transcriptional activation function. J Virol 80:4276-4285. http://dx.doi.org/10.1128/JVI.80.9.4276-4285.2006.
36. Wang X, Helfer CM, Pancholi N, Bradner JE, You J. 2013. Recruitment of Brd4 to the human papillomavirus type 16 DNA replication complex is essential for replication of viral DNA. J Virol 87:3871-3884. http://dx.doi.org/10.1128/JVI.03068-12.
37. Gauson EJ, Donaldson MM, Dornan ES, Wang X, Bristol M, Bodily JM, Morgan IM. 2015. Evidence supporting a role for TopBP1 and Brd4 in the initiation but not continuation of human papillomavirus 16 E1/E2-mediated DNA replication. J Virol 89:4980-4991. http://dx.doi.org/10.1128/JVI.00335-15.
38. Hollenhorst PC, McIntosh LP, Graves BJ. 2011. Genomic and biochemical insights into the specificity of ETS transcription factors. Annu Rev Biochem 80:437-471. http://dx.doi.org/10.1146/annurev.biochem.79.081507.103945.
39. Demeret C, Goyat S, Yaniv M, Thierry F. 1998. The human papillomavirus type 18 (HPV18) replication protein E1 is a transcriptional activator when interacting with HPV18 E2. Virology 242:378-386. http://dx.doi.org/10.1006/viro.1997.9023.
40. Titolo S, Pelletier A, Sauve F, Brault K, Wardrop E, White PW, Amin A, Cordingley MG, Archambault J. 1999. Role of the ATP-binding domain of the human papillomavirus type 11 E1 helicase in E2-dependent binding to the origin. J Virol 73:5282-5293.
41. Yasugi T, Benson JD, Sakai H, Vidal M, Howley PM. 1997. Mapping and characterization of the interaction domains of human papillomavirus type 16 E1 and E2 proteins. J Virol 71:891-899.
42. Morin G, Fradet-Turcotte A, Di Lello P, Bergeron-Labrecque F, Omichinski JG, Archambault J. 2011. A conserved amphipathic helix in the N-terminal regulatory region of the papillomavirus E1 helicase is required for efficient viral DNA replication. J Virol 85:5287-5300. http://dx.doi.org/10.1128/JVI.01829-10.